SpliSense Launches Phase 2b Trial for SPL84 Targeting Cystic Fibrosis Treatment #Israel #Jerusalem #cystic_fibrosis #SpliSense #SPL84

SpliSense Launches Phase 2b Trial for SPL84 Targeting Cystic Fibrosis Treatment #Israel #Jerusalem #cystic_fibrosis #SpliSense #SPL84